Myocardial protection in paediatric cardiac surgery: building an evidence-based strategy

Area of Science:

• Pediatric Cardiac Surgery
• Cardiovascular Research
• Myocardial Protection

Background:

• Cardioplegia is crucial for protecting the immature heart during congenital heart defect repair, mitigating ischemia/reperfusion injury.
• Pediatric myocardium differs from adult myocardium, showing increased sensitivity to calcium overload during reperfusion.
• Del Nido cardioplegia, designed for pediatric hearts, is common in North America, while St Thomas' blood cardioplegia is standard in the UK.

Purpose of the Study:

• To address the lack of phase 3 clinical trials comparing cardioplegia solutions in pediatric cardiac surgery.
• To investigate the optimal cardioplegia solution for children, considering age and clinical factors.
• To propose an evidence-based strategy for enhancing myocardial protection in pediatric cardiac surgery.

Main Methods:

• Conducting multicenter clinical trials of established cardioplegia techniques.
• Enhancing understanding of ischemia/reperfusion injury during cardioplegic arrest in children.
• Integrating clinical and genomic data for personalized medicine approaches.

Main Results:

• Current evidence is insufficient to definitively support one cardioplegia solution over another for pediatric use.
• Clinical equipoise exists regarding the best cardioplegia strategy for children.
• The impact of cardioplegia on long-term outcomes in pediatric patients remains largely unknown.

Conclusions:

• An evidence-based strategy is proposed to improve myocardial protection in pediatric cardiac surgery.
• Future research should focus on multicenter trials, understanding injury mechanisms, and personalized medicine.
• Long-term outcomes and patient-centered results must be considered in evaluating cardioplegia strategies.